Stay updated on REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial page.

Latest updates to the REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov record for the REGN3500 atopic dermatitis study is displayed, including its study details, eligibility criteria, locations, outcome measures, and supporting documents.SummaryDifference100%

- Check13 days agoChange DetectedThe footer revision number changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check27 days agoChange DetectedA site-wide NIH banner announces transition updates and a terminology change, while the site revision advances from v3.7.1 to v3.7.2. The clinical trial record remains inaccessible behind a 403 error.SummaryDifference1%

- Check41 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1; the study record remains inaccessible with a 403 error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the usual study details and indicating that access to the study record is blocked.SummaryDifference19%

- Check62 days agoChange DetectedThe page shows a revision badge update from v3.6.6 to v3.7.0, signaling a minor software/format update. This change does not modify study text, data, or user-facing content.SummaryDifference0.0%

Stay in the know with updates to REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial page.